CTC Licenses MIM Ammunition Tech to Ultra Defense Corp After Decade of Development
Event summary
- Concurrent Technologies Corporation (CTC) has licensed its patented Metal Injection Molded (MIM) ammunition technology to Ultra Defense Corp (UDC).
- The technology, developed in partnership with the U.S. Army since 2014, was unveiled as M-PACT™ at the 2026 SHOT Show.
- CTC received two U.S. patents (11465207 and 11493314) for the technology in 2023.
- MIM ammunition offers higher pressure capability (up to 100,000 PSI), increased muzzle velocity, and enhanced durability.
The big picture
This licensing deal marks a significant step in transitioning advanced defense technology from development to commercialization. The partnership between CTC and UDC highlights the growing trend of public-private collaborations in advancing defense capabilities. The technology's superior performance metrics could set a new standard in ammunition manufacturing, potentially disrupting traditional brass-based systems.
What we're watching
- Commercialization Pace
- The pace at which UDC scales M-PACT™ production for military, law enforcement, and civilian markets.
- Performance Validation
- How M-PACT™ performs in real-world conditions compared to traditional brass ammunition.
- Market Adoption
- Whether the defense and commercial sectors will widely adopt MIM ammunition technology.